Reach Us +1-218-451-2974


Mark Forrest Gordon | OMICS International
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Mark Forrest Gordon

Department of Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Ridgefield, USA


 Dr Mark Gorden ,Director at Boehringer Ingelheim Pharmaceuticals.His international experience includes various programes,contributions and participation in different countries for diverse fields of study.His research intrests reflect in his wide range of publications in various national and international journals.

Research Interest

 Mark researches and develops new therapies for Parkinson’s disease (PD) and cognitive impairments, such as Alzheimer’s disease. He is the clinical program leader of an international development project in PD. Mark represents BI on external consortia focusing on patient reported outcomes, biomarkers, and disease progression models.